Welcome to the Parkinson's Disease Knowledge Guide

Home
Understanding PD
Mirapexin^®/Sifrol^® (pramipexole)
References
Congresses & media events
- International congress schedule
- Media events
Glossary
Contact

Press releases

For Boehringer Ingelheim press releases please click on the Boehringer Ingelheim Corporate Newscentre here

Flash Player is needed to view the animation

Welcome to the PDKnowledgeGuide - A comprehensive website on Parkinson's disease and Mirapexin^®/Sifrol^® (pramipexole).

Hot topics

Boehringer Ingelheim receives approval from the European Commission for Mirapexin^®/Sifrol^® prolonged-release, once daily tablet for the treatment of Parkinson's disease

YouTube - parkinsonsmatters's Channel.jpg

Log on to
http://www.youtube.com/ user/parkinsonsmatters

Boehringer Ingelheim launch Parkinson’s Matters YouTube Channel

New research set to improve management of depressive symptoms in Parkinson's disease